Ascentage Pharma Group Internat Stock Forecast

Buy candidate since Aug 07, 2026 Loss -0.66%

The Ascentage Pharma Group Internat stock price fell by -0.658% on the last day (Monday, 10th Aug 2026) from $18.99 to $18.86. During the last trading day the stock fluctuated 1.29% from a day low at $18.62 to a day high of $18.86. The price has fallen in 6 of the last 10 days and is down by -0.16% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -5 thousand shares and in total, 3 thousand shares were bought and sold for approximately $63.94 thousand.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -7.78% during the next 3 months and, with a 90% probability hold a price between $14.72 and $18.39 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

AAPG Signals & Forecast

The Ascentage Pharma Group Internat stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $17.53 and $18.32. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, August 04, 2026, and so far it has risen 13.00%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Ascentage Pharma Group Internat stock

On the downside, the stock finds support just below today's level from accumulated volume at $17.13 and $17.01. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Ascentage Pharma Group Internat finds support just below today's level at $17.13. If this is broken, then the next support from accumulated volume will be at $17.01 and $16.77.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.240 between high and low, or 1.29%. For the last week the stock has had daily average volatility of 2.35%.

Our recommended stop-loss: $18.10 (-4.04%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 4 days ago.)

Trading Expectations (AAPG) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Ascentage Pharma Group Internat to open at $18.78, and during the day (based on 14 day Average True Range), to move between $18.50 and $19.22, which gives a possible trading interval of +/-$0.717 (+/-3.88%) up or down from last closing price. If Ascentage Pharma Group Internat takes out the full calculated possible swing range there will be an estimated 3.88% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $19.50 (3.39%) than the support at $17.13 (9.17%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Ascentage Pharma Group Internat stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 1.114 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $18.78 ( 0.424%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk